热门资讯> 正文
催化剂制药宣布到2026年2亿美元的股票回购计划
2025-10-01 20:31
- 触媒制药(CPRX) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Catalyst Pharmaceuticals (NASDAQ:CPRX) has authorized a new share repurchase program of up to $200M.
- The program allows for the repurchase of outstanding common stock between October 1, 2025, and December 31, 2026.
- Source: Press release
More on Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals: A Developing Story That's Cheap Enough
- Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript
- Catalyst Pharmaceuticals settles lawsuit with Lupin
- Catalyst Pharmaceuticals reaffirms $545M-$565M 2025 revenue guidance while accelerating FIRDAPSE oncology expansion
- Seeking Alpha’s Quant Rating on Catalyst Pharmaceuticals, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
